PPAR Agonists for the Prevention and Treatment of Lung Cancer. - Test2 - elhamkhani - TriplyDB

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

http://www.wikidata.org/entity/Q37681630

about

Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms.Leishmania infantum lipophosphoglycan induced-Prostaglandin E2 production in association with PPAR-γ expression via activation of Toll like receptors-1 and 2.Metabolism and Transcription in Cancer: Merging Two Classic Tales.Portulaca Extract Attenuates Development of Dextran Sulfate Sodium Induced Colitis in Mice through Activation of PPARγ.Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention

P2860

Q46269173-CEF2E334-5469-453D-80A4-B49765384B44 Q47131860-A3A6F162-1415-411B-A0FC-A6957CF12D86 Q49306241-22D8EC7B-2423-493C-8F3E-9D7617975F02 Q50317594-A41A5032-7B69-4971-81D5-EE556A74E1B8 Q52720174-59B4A636-27C4-4471-B0E6-2D4BDE5DBE37 Q55279633-CB3110BD-E23A-4DB0-93F5-CF369AEA6136 Q57135311-361DFEFF-69E5-40CC-B8FC-7BE64A033DCD

P2860

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

http://www.wikidata.org/entity/Q37681630

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

@en

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

@nl

type

label

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

@en

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

@nl

prefLabel

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

@en

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

@nl

P1433

Q37681630-D21109F0-C574-435E-949E-BD18DE3AD98F

P1476

Q37681630-4269361D-87B6-49D5-957B-A820C8F0CBF5

P2093

Q37681630-83AF9166-71C3-40F2-A671-4C117D7EAC51

P2860

Q37681630-0281ACFE-2C49-4E22-88D6-1604C439CA27

Q37681630-0460770C-651A-4FA1-BA29-F15A7B3D3117

Q37681630-08457C47-96F4-46A0-8801-3C9FB49E1E13

Q37681630-08ED2073-CD60-4533-A286-667815BCBFD6

Q37681630-09AF8081-3335-4168-BE4C-87D558E154A1

Q37681630-0CEEBB6C-2D10-4B96-AE54-C6AE28CBEE03

Q37681630-10EFB190-8837-45B7-B374-A52ABB8C1AF2

Q37681630-1407438D-E13A-4745-B302-FC0415879CFA

Q37681630-18F41349-9876-4242-876D-2A4029265399

Q37681630-20FD9F0C-17BD-4E5C-8383-0F74D4541510

P304

Q37681630-92083165-3955-4363-AF6B-A6D42D7FF104

P31

Q37681630-CBE73A4F-92B6-4B58-8C67-84B4DBF3ADDE

P356

Q37681630-48AD05DF-BB79-494C-A111-57C15E5D2B5D

P478

Q37681630-E20F114C-0FDC-4591-9AD7-33FB58ED9C3F

P50

Q37681630-77FEF61D-8F38-4996-9696-71BAE0D90955

Q37681630-85C1BAC1-6BBE-40B5-9B52-766973790AB7

Q37681630-9451E483-6D69-4B72-AB84-414FCC841540

P577

Q37681630-3D0AA978-2590-48AC-B500-519DE1E581D8

P698

Q37681630-8904729A-74BB-4FDB-8618-C5F0D5C77BFA

P932

Q37681630-FD178FD5-7D92-4F19-92F9-7838F206A104

P356

P1433

P1476

PPAR Agonists for the Prevention and Treatment of Lung Cancer.

@en

P2093

Asoka Banno

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of PPARs in Cancer

The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

Molecular recognition of nitrated fatty acids by PPARγ

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

The mechanisms of action of PPARs

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Cancer statistics, 2016

Tumorigenesis and the angiogenic switch

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

P304

8252796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/8252796

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Sowmya P Lakshmi

Aravind T Reddy

P577

2017-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28316613

http://www.w3.org/2001/XMLSchema#string

P932

5337885

http://www.w3.org/2001/XMLSchema#string